Identification and characterization of three new alternatively spliced μ-opioid receptor isoforms

YX Pan, J Xu, E Bolan, C Abbadie, A Chang… - Molecular …, 1999 - ASPET
YX Pan, J Xu, E Bolan, C Abbadie, A Chang, A Zuckerman, G Rossi, GW Pasternak
Molecular pharmacology, 1999ASPET
We have identified four new μ-opiod receptor (MOR)-1 exons, indicating that the gene now
contains at least nine exons spanning more than 200 kilobases. Replacement of exon 4 by
combinations of the new exons yields three new receptors. When expressed in Chinese
hamster ovary cells, all three variants displayed high affinity for μ-opioid ligands, but κ and δ
drugs were inactive. However, there were subtle, but significant, differences in the binding
profiles of the three variants among themselves and from MOR-1. Immunohistochemically …
We have identified four new μ-opiod receptor (MOR)-1 exons, indicating that the gene now contains at least nine exons spanning more than 200 kilobases. Replacement of exon 4 by combinations of the new exons yields three new receptors. When expressed in Chinese hamster ovary cells, all three variants displayed high affinity for μ-opioid ligands, but κ and δ drugs were inactive. However, there were subtle, but significant, differences in the binding profiles of the three variants among themselves and from MOR-1. Immunohistochemically, the major variant, MOR-1C, displayed a regional distribution quite distinct from that of MOR-1. Region-specific processing also was seen at the mRNA level. Antisense mapping revealed that the four new exons were all involved in morphine analgesia. Together with two other variants generated from alternative splicing of exon 4, there are now six distinct MOR-1 receptors.
ASPET